- Research article
- Open Access
Comparative analysis of resistant and susceptible macrophage gene expression response to Leishmania majorparasite
BMC Genomicsvolume 14, Article number: 723 (2013)
Leishmania are obligated intracellular pathogens that replicate almost exclusively in macrophages. The outcome of infection depends largely on parasite pathogenicity and virulence but also on the activation status and genetic background of macrophages. Animal models are essential for a better understanding of pathogenesis of different microbes including Leishmania.
Here we compared the transcriptional signatures of resistant (C57BL/6) and susceptible (BALB/c) mouse bone marrow-derived macrophages in response to Leishmania major (L. major) promastigotes infection.
Microarray results were first analyzed for significant pathways using the Kyoto Encylopedia of Genes and Genomes (KEGG) database. The analysis revealed that a large set of the shared genes is involved in the immune response and that difference in the expression level of some chemokines and chemokine receptors could partially explain differences in resistance. We next focused on up-regulated genes unique to either BALB/c or C57BL/6 derived macrophages and identified, using KEGG database, signal transduction pathways among the most relevant pathways unique to both susceptible and resistant derived macrophages. Indeed, genes unique to C57BL/6 BMdMs were associated with target of rapamycin (mTOR) signaling pathway while a range of genes unique to BALB/c BMdMs, belong to p53 signaling pathway. We next investigated whether, in a given mice strain derived macrophages, the different up-regulated unique genes could be coordinately regulated. Using GeneMapp Cytoscape, we showed that the induced genes unique to BALB/c or C57BL/6 BMdMs are interconnected. Finally, we examined whether the induced pathways unique to BALB/c derived macrophages interfere with the ones unique to C57BL/6 derived macrophages. Protein-protein interaction analysis using String database highlights the existence of a cross-talk between p53 and mTOR signaling pathways respectively specific to susceptible and resistant BMdMs.
Taken together our results suggest that strains specific pathogenesis may be due to a difference in the magnitude of the same pathways and/or to differentially expressed pathways in the two mouse strains derived macrophages. We identify signal transduction pathways among the most relevant pathways modulated by L. major infection, unique to BALB/c and C57BL/6 BMdM and postulate that the interplay between these potentially interconnected pathways could direct the macrophage response toward a given phenotype.
Leishmania lives as an obligate intracellular parasite within mammalian hosts. Host-Leishmania interactions are a complex interplay between a host’s defense mechanisms and the microorganism’s attempts to circumvent these defenses. The outcome of infection depends on parasite pathogenicity and virulence but also largely on the activation status and the genetic background of macrophages, the major target cells for parasite replication, also involved in the early events of pathogen infection.
Several studies have shown that L. major and other Leishmania species induces alteration in macrophages gene expression [1–6] and other have compared the effect of different Leishmania species including L. major on a given cell type . However, only a recent study has highlighted the differences between the responses of murine macrophages from two inbred mouse strains to L. amazonensis infection .
Animal models are essential for a better understanding of pathogenesis of different microbes and the cutaneous leishmaniasis murine model has been widely used to characterize the response against L. major. In particular, these studies have capitalized on two different mouse strains with contrasted behavior in response to parasite infection: the BALB/c mice which develop severe lesions at the site of cutaneous inoculation  and the C57BL/6 mice with a self-healing lesion [9, 10]. In this study we compared the transcriptomic signature of BALB/c and C57BL/6 derived macrophages and investigated whether susceptibility or resistance to L. major might reflect differences in macrophage responses to this parasite.
To distinguish the gene sets that belong to a known network of genes involved in biologically significant pathways, an in silico comparison was made using the KEGG database [11, 12]. This analysis revealed shared and distinct expression profiles and showed that strains specific pathogenesis may be due to a difference in the magnitude of the same pathways but also to differentially expressed and potentially interconnected pathways in the two mouse strains derived macrophages.
Tunisian strain of L. major promastigotes (MHOM/TN/95/GLC94 zymodeme MON25) were grown at 26°C in RPMI 1640, supplemented with 2 mM L-glutamine, 10% heat inactivated foetal calf serum, penicillin (100 U/ml) and streptomycin (10 mg/ml). Metacyclic rich fraction obtained using Ficoll gradient were used in all experiments. Briefly, stationary phase cultures of Leishmania were centrifuged at 5,000 g for 10 min at room temperature and resuspended in 2 ml of PBS. The cell suspensions were then loaded onto a Ficoll gradient composed, from the bottom of 2 ml of 20%, 5 ml of 10% and 5 ml of 5% Ficoll diluted in PBS. The gradient was next centrifuged at 1,300 g for 10 min at room temperature. The metacyclic promastigotes were recovered on the top of 10% Ficoll layer.
Cells isolation and culture
BALB/c and C57BL/6 mice (Elevage Janvier) were killed and hind legs removed for BMdM isolation. Briefly, femurs and tibias were flushed with RPMI 1640 using a 25-gauge needle. Contaminating erythrocytes were lysed through the addition of Geys lysis solution (ammonium chloride 1.5 M, EDTA 0.1 mM, pH 7.3). All cells were incubated in T75 culture flasks at 1.5 106 cell per ml in RPMI 1640 media supplemented with 2 mM L-glutamine, 10% heat inactivated foetal calf serum (Perbio science, Brebières, France), penicillin (100 U/ml) and streptomycin (10 mg/ml) and 80 ng/ml M-CSF (Peprotech, Neuilly sur Seine, France) overnight for stromal cell elimination. Non-adherent, immature macrophages were transferred to fresh culture-treated Petri dishes (Nunc, USA) and grown for 7 days, with re-feeding on day 3, to induce macrophage differentiation. BMdM purity was analyzed through the evaluation of phenotypic expression of specific macrophage subset surface marker (F4/80) by Flow cytometry. Generated macrophages were assessed by flow cytometry for expression of F4/80 (80-90% were positive).
All mouse work was done according to the directive 86/609/EEC of the European parliament and of the council on the protection of animals used for scientific purposes. Approval for mice experiments was obtained from the ethic committee of Institute Pasteur of Tunis with ethics approval number 1204.
106 BMdM Cells were seeded in 1 ml complete media on 24 well plates and subjected to adhere overnight at 37°C in 5% CO2. They are afterwards, incubated at a parasite to cell ratio of approximately 10:1 with Ficoll purified metacyclic promastigotes of L. major. After the desired time of incubation, the extracellular parasites were washed out and the cells were harvested to prepare samples. The macrophages were fixed, Giemsa-stained and counted to calculate the number of amastigotes per 100 macrophages to insure for homogenate cell infection under the different conditions.
RNA isolation, microarray hybridization and normalization
The RNA isolation and quantification, the hybridization to the GeneChip Mouse Gene 1.0 ST array (Affymetrix, Santa Clara, CA) were performed as previously described . Each infection and control time points were performed in triplicate, using different preparations of BMdMs, and processed independently to give three biological replicates. QC analysis was performed before and after normalization using BoxPlot of total intensities, MAPlots for all replicates and PCAplots. All microarrays of this study passed the quality control.
The intrachip and interchip normalisation were performed as previously described . Expression analysis used the R Bioconductor package Limma  to identify genes that met statistical (P < 0.05 after adjustment according to the method of Benjamini and Hochberg and fold-change criteria (at least a 1.5-fold change) for differential expression using the following contrasts: macrophages infected with live parasites at a given time point versus non infected macrophages incubated with vehicule (media) for the same time. The same contrast was used for heat-killed L. major-infected macrophages. Macrophage genes modulated during the kinetics were detected.
In accordance with MIAME (Minimum Information About a Microarray Experiments) regulations , all data were deposited into GEO (Gene Expression Omnibus) database at http://www.ncbi.nlm.nih.gov/geo under the accession number GSE31995 and GSE31996.
Quantitative real time PCR
Transcripts significantly modulated by Leishmania infection over the time were identified and a subset of these genes confirmed by reverse-transcription quantitative real-time PCR (RT-qPCR) as previously described . The same RNA samples were used for both affymetrix microarray analysis and qRT-PCR experiments.
Data pre- processing
Original data represented as matrix was subject to a normalization pipeline, which consists in i) merging different triplicates for each condition into a single data point reducing the matrix columns from 45 columns to 15 columns and one additional column for non infected at t = 0 h. ii) To avoid gene duplicates, we merged probes with same gene ID which automatically shrinks the matrix so that all rows of probes from the same gene are merged into one average row using only gene ID as unique identifier. iii) In order to remove systematic variations that may occur because of reasons other than biological differences between RNA samples, a Quantile Normalization has been done on the expression data. iv) A fold change of 2 was used as a cutoff to further reduce the data and keep highly differential genes and a final standardization of the data was done on the mean (0) and standard deviation (1) of the final gene set on the expression matrix.
To compare conditions in order to extract highly differentially expressed genes, our strategy consists on the use of a supervised grouping using T-test as a statistical approach to extract significantly variable genes. Similar strategy was used for either BALB/c or C57BL/6. We first compared the group of uninfected conditions (NI) (at the different time points (1, 3, 6, 12 and 24 h)) to the infected group (P) (at the same time points). Similar comparison was performed between the parasite infected (P) and killed parasite (Kp) infected group. Selected probes obey the p-value cutoff of 0.05 using FDR as multiple tests correction. The outcome of these steps is groups of genes that are down-regulated or up-regulated depending on their expression values.
In order to locate in which pathway our up-regulated and down-regulated genes are enriched, we relied on the usage of KEGG pathway for this analysis. We used a stringent p-value cutoff of 1E-4 and the condition of having at least 4 genes within each enriched pathway. The results consist in a set of enriched pathways for up-regulated genes and down-regulated genes. Gene lists of each pathway found are extracted for further analysis. We run an additional pathway enrichment analysis based on gene occurrence in both BALB/c and C57BL/6 as well as genes that are unique to each of them. The goal behind this additional analysis is to detect pathways that are specific to each mice strain under the same infection conditions. The analysis of specific genes may inform on interconnected pathways that may be activated or deactivated depending on the gene sets involved.
Protein-protein interaction networks
In order to discover relationships between genes products in our up-regulated and down-regulated sets we used STRING DB as it contains an accurate and updated data on physical and functional interactions. STRING also allows to predict activation/repression relationships between different nodes of the same graph .
In furtherance of highlighting relationship between differentially expressed genes and corresponding pathways, we used all up-regulated genes in BALB/c and C57BL/6 and studied genes interaction within the same pathway and genes interactions across different pathways. The analysis was done using GENMAPP-CS cytoscape plugin (http://www.genmapp.org/beta/genmappcs/). Orphan nodes were removed from the network to highlight the direct interactions between different genes.
Infection rates and parasites load were equivalent
We first established cell culture and infection conditions to ensure that the levels of infection of the bone marrow derived macrophages (BMdM) isolated from the two mice strains were equivalent. The same cell/parasite ratio (1:10) was found to give similar infection rate and parasite load. Light microscopy on Giemsa stained chamber slides of infected BMMs showed that the percentage of infected cells and the mean amastigote loads were comparable between L. major infected C57BL/6 and BALB/c BMdMs in each of the three experimental replicates used in this study (Table 1). Subsequent microarray analysis was carried out on each of the three biological replicates.
GeneChip Mouse Gene 1.0 ST arrays were used to analyse global changes in gene transcripts to generate a pool of genes that was statistically significant (p-value < 0.05) and a fold change cut-off of 2. Of the 18 899 genes represented on the array, our analysis of mRNA expression in mice BMdM infected by live parasites showed that a total of 1175 genes were expressed differentially over the time course (with 658 down- and 517 up-regulated) in BALB/c BMdM and approximately the same number of genes (1174) was differentially modulated (663 down- and 511 up-regulated) in C57BL/6 BMdM. The microarrays analysis also revealed that as a result of Leishmania infection, the expression of 768 genes were shared between BALB/c and C57BL/6 BMdMs, with 434 genes down-regulated and 334 up-regulated (Figure 1). The relative expression of selected differentially expressed genes from the microarray data was further examined by RT-qPCR on the same samples that those analyzed by microarray analysis. Data from RT-qPCR analysis (Additional file 1: Table S1) were consistent with the results obtained by microarrays, albeit with magnitudes different from, and often higher than, those recorded by the microarray analysis.
Further analysis showed that 768 genes among the commonly altered in BALB/c and C57BL/6 BMdMs in response to infection, fall into 45 KEGG pathways. The genes unique to BALB/c correspond to 22 and those unique to C57BL/6 correspond to 25 pathways with a p-value less than 0.05 (Additional file 2: Table S2).
Shared expression profiles in susceptible and resistant Leishmaniainfected BMdM and strains specific pathogenesis
Functional analysis determined that the shared genes were primarily associated with metabolic pathways (including glycolysis/Gluconeogenesis, Galactose, Fructose and mannose metabolism, and N-Glycan biosynthesis). Analysis and biological validation of a set of those metabolic pathways have been previously reported . L. major also modulates different other genes implicated in Fc gamma R-mediated phagocytosis, chemokines, and Toll like receptor signaling pathway. The expression of different genes involved in host cell defense pathways and especially in iron metabolism is also altered by the infection. Indeed, almost all the intracellular pathogens require iron to develop a productive infection and restricting the availability of iron is considered as an important strategy for defense against infections. L. major inhibits the mRNA expression of the genes encoding transferring, holotransferrin receptor and Ferroportin 1 (Slc40a1) which suggest that the parasite limits the uptake and the export of iron. L. major also enhances the induction of the mRNA of Nramp2 a protein implicated in the iron efflux from the endosomes suggesting more iron accumulation inside the cytosol. Otherwise, in both susceptible and resistant Leishmania major infected macrophages, the parasite induces the transcription down-regulation of most lysosomal proteins. These include different Glycosidases (Gusb, Galc), Sulfatases (Sgsh), membrane proteins (Laptm5, Lamp1), most V-ATPases and others lysosomal proteases such cathepsin.
We further analyzed the expression and kinetics of a panel of cytokines and chemokines during L. major infection in a comparative study of genetically resistant C57BL/6 and susceptible BALB/c mice. Among the chemokines responsible of leukocytes recruitment, L. major induces the mRNA expression of Ccl2 (MCP1), macrophage inflammatory protein-1α (Mip-1α/Ccl3) and Mip-1β/Ccl4. The infection also activates the transcription of Cxcl1, Cxcl2 that regulate the influx of PMNs, Cxcl3 that controls migration of monocytes, Cxcl9 the Th1-attracting protein and the interferon-γ - inducible protein-10 (IP-10/Ccxl10). The expression of Cxcl1, Cxcl2 and Cxcl3 mRNA induced by both live and killed parasites is not modulated to the same extent in the two mice strains BMdM. Indeed, as assessed by qRT-PCR, the mRNA induction of these chemokines is respectively six, five and four times higher in the C57BL/6 BMdM (Additional file 1: Table S1). Moreover, in the macrophage derived from susceptible mice, the transcription induced by live parasites seems actively repressed when compared to the one induced by killed parasites. The mRNA expression of Ccl3 is similarly regulated. L. major promastigotes induce rapid and transient expression of murine Ccl2 that besides attracting monocytes and macrophages, can attract other cells such as NK and DCs expressing the chemokine receptor Ccr2. However, the infection represses the transcription of Ccr2 receptor. By contrast, parasites activate the mRNA expression of Ccrl2 in macrophages derived from the two mice strain. This expression is however 5 times more important in resistant mice. The mRNA expression of Cxcl9, slightly increases in response to L. major during early infection in BMdM derived from the two mice strains. However, while this expression is quiet back to the baseline 24 hpi in BALB/c BMdM, it starts to significantly be enhanced beginning from 12 hpi in the C57BL/6 BMdM.
Signal transduction pathways are among the most relevant pathways unique to BALB/c and C57BL/6 macrophages
We next identified differentially expressed genes unique to BALB/c and C57BL/6 derived macrophages and performed enrichment analysis of these genes based on KEGG database (Additional file 2: Table S2). Pathways with p-values less than 0.05 were considered statistically significant. This analysis clearly identifies signaling pathways among the most relevant pathways modulated by L. major promastigotes. Indeed, the results show that down-regulated genes unique to macrophages derived from resistant mice were related among others to MAPK signaling pathways whereas a set of up-regulated genes were involved in the mTOR signaling pathway, Erbb and Insulin signaling pathways (Additional file 2: Table S2). Among the down-regulated genes unique to susceptible mice we listed those implicated in the Notch and chemokine signaling pathways. The up-regulated genes unique to BALB/c derived macrophages are implicated in p53 signaling pathway (Additional file 2: Table S2). Among these p53-dependent genes modulated by L. major, we found the mouse double minute 2 (Mdm2) an inhibitor of p53, the insulin growth factor 1 (Igf1), some genes implicated in cell cycle genes such Gadd45a or b, and genes implicated in the apoptotic pathway (Bid).
Furthermore, we investigated whether, in a given mice strain derived macrophages, these coordinately regulated unique genes may be interconnected. We focused on up-regulated genes and up-loaded on GENMAPP-CS the lists of the genes unique to BALB/c and C57BL/6 derived macrophages. This analysis shows (Figure 2) that after the removing of orphan nodes, the genes (and pathways) identified to be significantly induced by L. major in macrophages derived from susceptible mice, mostly unique to BALB/c appeared to be interconnected except for the p53 signaling pathway (Figure 2). These fall into several pathways including glycolysis/Gluconeogenesis (AldoC, Eno2, Pdhb), antigen processing, cellular pH regulation (VATP-ases, Cathepsin), immune response (TNFα, IL-1α). Our results also show that several genes and pathways induced by L. major in C57BL/6 macrophages are linked to the mammalian Target of Rapamycine (mTOR) signaling pathway (Figure 3). These pathways include the chemokine, the toll like receptors and the insulin signaling pathways.
As p53 and mTOR signaling pathways are known to be interconnected, the list of L. major-activated genes belonging to these two pathways were uploaded on STRING database. As illustrated in Figure 4, protein-protein interaction analysis, show that these two pathways are independent with Igf1, a p53 target gene, showing up as a major node in this network.
We compared transcriptomic signature of susceptible and resistant bone marrow derived macrophages in response to L. major infection. The analysis identifies both shared and unique set of transcribed genes.
Evidence for early inflammatory response have been presented for either human  or murine  macrophages exposed to L. major. Host defense is highly dependent on mobile leucocytes and cell trafficking is largely mediated by the interactions of chemokines with their specific receptors expressed on the surface of leucocytes. Chemokines and their receptors play a critical role in the regulation of leukocyte recruitment during leishmaniasis. Chemokine receptors work in concert or succession to successfully recruit to sites of inflammation, effectors cells such PMNs, macrophages and NK cells in order to combat skin infection with Leishmania. Chemokines also have roles in adaptive immunity, in macrophage activation and parasite killing.
Taken together, our results show that the expression of these chemokines and some of their receptors is induced in both mice strain derived macrophages with however, a more rapid and heightened expression in C57BL/6 BMdMs. Differential expression of chemokines and chemokine receptors may lead to difference in immune cells influx. This difference in inflammatory cells recruitment can affect T cells activation which could explain differences in resistance. In accordance with this hypothesis and using electron microscopy combined with enzyme-histochemical methods, qualitative and quantitative differences in the pattern of infiltration at the site of infection have been reported between L. major infected BALB/c and C57BL/6 mice . Indeed, while in susceptible BALB/c mice the persistent pattern of infiltration contains PMNs and mononuclear phagocytes, in the resistant C57BL/6 mice, this cellular infiltrate contain besides PMNs, mononuclear phagocytes that rapidly became the dominant population of cells. However, a more recent histopathological study that had looked to the patterns of tissue responses at the site of the infection and in the draining lymph nodes shows no correlation with resistance or susceptibility . The outcome of the lesions and infection depend also on the parasite replication capacity. The transcription of the Macrophage chemoattractant protein-1 (MCP-1/Ccl2) and MIP-1α/Ccl3 that can trigger iNOS activity and promote parasite killing by the host macrophage, is repressed (compared to the one induced by Kp) in C57BL/6 derived macrophages . On the other hand, besides its role as Th1-attracting chemokine, Cxcl9 has also been described as a defensin-like protein with antibacterial activity . An important enhancement of the mRNA coding for this chemokine having a potential anti-Leishmania activity could also contribute to the resistant phenotype of C57BL/6 mice.
Thus, strains specific pathogenesis could be due to a difference in the magnitude of the same pathways. However, differentially expressed genes and their corresponding enriched pathways in the macrophages derived from susceptible and resistant mice are potentially the key to understand the different pathologies associated with the two mouse strains.
Among the genes unique to BALB/c derived macrophages we found a set of genes implicated in the p53 signaling pathway. Our data and particularly the mRNA expression of mouse double minute 2 (Mdm2) suggest the activation of this pathway. Indeed, Mdm2 which directly binds to and forms a complex with p53, causes its ubiquitinization and proteasomal degradation, and exports it out of the nucleus, is also a target gene of p53 transcription factor .
Our results also show that the induced genes unique to susceptible BMdMs fall into different interconnected pathways. These linked pathways correspond among other to immune response and metabolic pathways (glycolysis and gluconeogenesis). The GENMAPP-CS analysis shows that the p53 pathway is not linked to the others. However, this analysis does not allow the visualization of indirect connections and only considers genes unique to BALB/c derived macrophages. Shared genes may also be interconnected to those selected by GENMAPP-CS and may contribute to the physiopathology of the disease. This could be the case for Glutaminase 2 (Gls2), a p53 target gene . Gls2 catalyzes the hydrolysis of glutamine which feeds the TCA cycle by providing α-ketoglutarate from glutamate and represent an alternative to glucose as the fuel for bioenergetic pathways. Besides cellular energy metabolism, Gls2 regulates antioxidant defense function in cells by increasing reduced glutathione (GSH) levels and decreasing ROS levels, which in turn protects cells from oxidative stress (e.g., H2O2)-induced apoptosis [23, 24]. This gene is heavily transcribed in the macrophages derived from the susceptible mice (Additional file 1: Table S1). Thus, if expressed, this protein may protect the cells from the apoptosis induced by the ROS which may allow the parasite to survive and thus may contribute to the susceptible phenotype. By contrast, in macrophages derived from resistant mice, the transcription of Gls2 is less important. Compared to the transcription induced by killed parasites the one induced by live promastigotes seems to be actively repressed. The relative repression or attenuated transcription of this gene may be in favor of Leishmania-infected macrophage elimination by apoptosis and could thus contribute to the resistant phenotype of C57BL/6 mice.
STRING analysis performed to highlight possible direct relationship between the p53 pathway unique to BALB/c and mTOR pathway unique to resistant BMdMs, reveals the Igf1 protein as a major node in this network (Figure 4). The expression of Igf1 another p53 target gene unique to BALB/c derived macrophages, seems to play a role in the susceptible phenotype. Indeed, the protein encoded by this gene has been described as a growth-promoting factor for Leishmania promastigotes and amastigotes [25, 26] able to induce the activation of arginase and the reciprocal inhibition of NOS2 pathway in BALB/c derived macrophages . Igf1 protein is also able to repress the expression of Vegfa an mTOR target gene. This cytokine which function is still unclear, has been recently detected in the macrophages derived from susceptible lesions but not in the ones derived from resistant lesions .
Different arguments assign p53 as a signaling pathway able to direct the macrophage toward a susceptible phenotype. We thus may assume that a signal could allow the preferential activation of one or the other pathway within the macrophage and thus direct the outcome of Leishmania disease.
Our results also show that the mTOR signaling pathway unique to resistant mice derived macrophages directly regulates a range of induced pathways unique to resistant BMdMs. These include chemokines, TLR and insulin signaling pathways. However, mTOR could also regulates glycolysis and lipids synthesis through the activation of a transcriptional program affecting metabolic gene targets of sterol regulatory element-binding protein (SREBP1) and hypoxia-inducible factor (HIF1α) known to be activated in Leishmania infected macrophages (data not shown) . It has been recently reported  that L. major subverts the translation machinery of the macrophages through activation of the translational repressor 4EBP1, a mechanism that involves mTOR cleavage and the consequent inhibition of mTORC1. However, in our hands, L. major parasite induces the activation of mTOR phosphorylation in macrophages. This phosphorylation is observed 15 min post-infection and is still present 3 hours post-infection (data not shown).
Recent studies highlighted a new metabolic role for p53 transcription factor which is linked to energy metabolism through the regulation of glycolysis and oxidative phosphorylation . The effects of p53 on glycolytic pathways are likely to be cell and context dependent. P53 can be a negative regulator of glycolysis through the activation of TIGAR  and the down-regulation of GLUT1 and GLUT4 glucose transporter genes transcription , but can also enhance some steps in this pathway such as HK2 . Therefore, p53 and mTOR signaling machineries can clearly cross-talk and coordinately regulate different functions.
Subversion of macrophage signaling pathways is a key strategy used by the parasite to evade microbicidal effector function of these cells [35, 36]. Leishmania parasite has the capacity to interfere and manipulate the intracellular macrophage signaling pathways. Activation of CD40 pathway has been reported to protect the cell from Leishmania infection . A strong CD40 stimulation results in p38MAPK-dependent IL-12 production, whereas a weaker stimulation induces ERK1/2 mediated IL-10 production. During Leishmania infection, the level of CD40-induced ERK1/2 phosphorylation and IL-10 production increase, whereas p38MAPK activation and IL-12 production decrease, showing that a single membrane receptor can regulate two counteracting effector functions by modulating two reciprocally signaling pathways . Such reciprocity has been suggested to arise from a signaling threshold that allows preferential activation of one or the other signaling module associated with the receptor .
Clearly, a signal is able to regulate two counteracting effector functions by modulating two reciprocally signaling pathways.
In summary, we identified a global gene expression pattern that was shared and distinct between the macrophages derived from susceptible and resistant mice and showed that susceptibility or resistance to L. major may reflect differences in macrophage responses to this parasite.
Bone marrow derived macrophage
Quantitative real time PCR
Gene expression omnibus
Minimum information about a microarray experiments
Kyoto Encyclopedia of genes and genomes.
Buates S, Matlashewski G: General suppression of macrophage gene expression during Leishmania donovani infection. J Immunol. 2001, 166 (5): 3416-3422.
Chaussabel D, Semnani RT, McDowell MA, Sacks D, Sher A, Nutman TB: Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood. 2003, 102 (2): 672-681. 10.1182/blood-2002-10-3232.
Rodriguez NE, Chang HK, Wilson ME: Novel program of macrophage gene expression induced by phagocytosis of Leishmania chagasi. Infect Immun. 2004, 72 (4): 2111-2122. 10.1128/IAI.72.4.2111-2122.2004.
Guerfali FZ, Laouini D, Guizani-Tabbane L, Ottones F, Ben-Aissa K, Benkahla A, Manchon L, Piquemal D, Smandi S, Mghirbi O, et al: Simultaneous gene expression profiling in human macrophages infected with Leishmania major parasites using SAGE. BMC Genomics. 2008, 9: 238-10.1186/1471-2164-9-238.
Osorio y Fortea J, de La Llave E, Regnault B, Coppee JY, Milon G, Lang T, Prina E: Transcriptional signatures of BALB/c mouse macrophages housing multiplying Leishmania amazonensis amastigotes. BMC Genomics. 2009, 10: 119-10.1186/1471-2164-10-119.
Rabhi I, Rabhi S, Ben-Othman R, Rasche A, Consortium S, Daskalaki A, Trentin B, Piquemal D, Regnault B, Descoteaux A, et al: Transcriptomic signature of Leishmania infected mice macrophages: a metabolic point of view. PLoS Negl Trop Dis. 2012, 6 (8): e1763-10.1371/journal.pntd.0001763.
Gregory DJ, Sladek R, Olivier M, Matlashewski G: Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression. Infect Immun. 2008, 76 (3): 1186-1192. 10.1128/IAI.01320-07.
Tacchini-Cottier F, Zweifel C, Belkaid Y, Mukankundiye C, Vasei M, Launois P, Milon G, Louis JA: An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major. J Immunol. 2000, 165 (5): 2628-2636.
Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D: A natural model of Leishmania major infection reveals a prolonged “silent” phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol. 2000, 165 (2): 969-977.
Sacks D, Noben-Trauth N: The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol. 2002, 2 (11): 845-858. 10.1038/nri933.
Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M: The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004, 32 (Database issue): D277-D280.
Moriya Y, Itoh M, Okuda S, Yoshizawa AC, Kanehisa M: KAAS: an automatic genome annotation and pathway reconstruction server. Nucleic Acids Res. 2007, 35 (Web Server issue): W182-W185.
Smyth GK, Yang YH, Speed T: Statistical issues in cDNA microarray data analysis. Methods Mol Biol. 2003, 224: 111-136.
Edgar R, Barrett T: NCBI GEO standards and services for microarray data. Nat Biotechnol. 2006, 24 (12): 1471-1472. 10.1038/nbt1206-1471.
Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, et al: The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011, 39 (Database issue): D561-D568.
Ramirez C, Diaz-Toro Y, Tellez J, Castilho TM, Rojas R, Ettinger NA, Tikhonova I, Alexander ND, Valderrama L, Hager J, et al: Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response. PLoS Negl Trop Dis. 2012, 6 (10): e1866-10.1371/journal.pntd.0001866.
Teixeira MJ, Teixeira CR, Andrade BB, Barral-Netto M, Barral A: Chemokines in host-parasite interactions in leishmaniasis. Trends Parasitol. 2006, 22 (1): 32-40. 10.1016/j.pt.2005.11.010.
Beil WJ, Meinardus-Hager G, Neugebauer DC, Sorg C: Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. J Leukoc Biol. 1992, 52 (2): 135-142.
Dantas Cangussú S, Carvalho de Souza C, França Campos C, Quercia Vieira L, Crocco Afonso L, Esteves Arantes R-M: Histopathology of Leishmania major infection: revisiting L. major histopathology in the ear dermis infection model. Mem Inst Oswaldo Cruz, Rio de Janeiro. 2009, 104 (6): 918-922. 10.1590/S0074-02762009000600017.
Bhattacharyya S, Ghosh S, Dasgupta B, Mazumder D, Roy S, Majumdar S: Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide. J Infect Dis. 2002, 185 (12): 1704-1708. 10.1086/340820.
Balogh EP, Faludi I, Virok DP, Endresz V, Burian K: Chlamydophila pneumoniae induces production of the defensin-like MIG/CXCL9, which has in vitro antichlamydial activity. Int J Med Microbiol. 2011, 301 (3): 252-259. 10.1016/j.ijmm.2010.08.020.
Barak Y, Juven T, Haffner R, Oren M: mdm2 expression is induced by wild type p53 activity. EMBO J. 1993, 12 (2): 461-468.
Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z: Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci U S A. 2010, 107 (16): 7455-7460. 10.1073/pnas.1001006107.
Mates JM, Segura JA, Martin-Rufian M, Campos-Sandoval JA, Alonso FJ, Marquez J: Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer. Curr Mol Med. 2013, 13 (4): 514-534. 10.2174/1566524011313040005.
Goto H, Gomes CM, Corbett CE, Monteiro HP, Gidlund M: Insulin-like growth factor I is a growth-promoting factor for Leishmania promastigotes and amastigotes. Proc Natl Acad Sci U S A. 1998, 95 (22): 13211-13216. 10.1073/pnas.95.22.13211.
Gomes CM, Goto H, Ribeiro Da Matta VL, Laurenti MD, Gidlund M, Corbett CE: Insulin-like growth factor (IGF)-I affects parasite growth and host cell migration in experimental cutaneous leishmaniasis. Int J Exp Pathol. 2000, 81 (4): 249-255.
Vendrame CM, Carvalho MD, Rios FJ, Manuli ER, Petitto-Assis F, Goto H: Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro. Scand J Immunol. 2007, 66 (2–3): 287-296.
Araujo AP, Arrais-Silva WW, Giorgio S: Infection by Leishmania amazonensis in mice: a potential model for chronic hypoxia. Acta Histochem. 2012, 114 (8): 797-804. 10.1016/j.acthis.2012.01.007.
Duvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S, et al: Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell. 2010, 39 (2): 171-183. 10.1016/j.molcel.2010.06.022.
Jaramillo M, Gomez MA, Larsson O, Shio MT, Topisirovic I, Contreras I, Luxenburg R, Rosenfeld A, Colina R, McMaster RW, et al: Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection. Cell Host Microbe. 2011, 9 (4): 331-341. 10.1016/j.chom.2011.03.008.
Zhang XD, Qin ZH, Wang J: The role of p53 in cell metabolism. Acta Pharmacol Sin. 2010, 31 (9): 1208-1212. 10.1038/aps.2010.151.
Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH: TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell. 2006, 126 (1): 107-120. 10.1016/j.cell.2006.05.036.
Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E: The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004, 64 (7): 2627-2633. 10.1158/0008-5472.CAN-03-0846.
Mathupala SP, Ko YH, Pedersen PL: Hexokinase II: cancer’s double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene. 2006, 25 (34): 4777-4786. 10.1038/sj.onc.1209603.
Denkers EY, Butcher BA: Sabotage and exploitation in macrophages parasitized by intracellular protozoans. Trends Parasitol. 2005, 21 (1): 35-41. 10.1016/j.pt.2004.10.004.
Gregory DJ, Olivier M: Subversion of host cell signalling by the protozoan parasite Leishmania. Parasitology. 2005, 130 (Suppl): S27-S35.
Soong L, Xu JC, Grewal IS, Kima P, Sun J, Longley BJ, Ruddle NH, McMahon-Pratt D, Flavell RA: Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity. 1996, 4 (3): 263-273. 10.1016/S1074-7613(00)80434-3.
Mathur RK, Awasthi A, Wadhone P, Ramanamurthy B, Saha B: Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat Med. 2004, 10 (5): 540-544. 10.1038/nm1045.
To Dr. A. Sassi and Pr. E. Ennaifer for blind determining of the percentage and the mean amastigote loads of infected cells.
The SysCo Consortium and this work were funded by the European Union under its 6th Framework Programme (LSHG-CT-2006-037231).
Sysco consortium: Attia Hanène, Ben Miled Slimane, Benkahla Alia, Bruno Roman, Cazenave Pierre-André, Checkmeneva Elena, Daskalaki Andriani, Dellagi Koussay, Gabdoulline Razif, Ghedira Kais, Guerfali Fatma Z., Gustin Cindy, Herwig Ralf, Hide Winston, Hofmann Oliver, Hornischer Klaus, Kel Alexander, Kiselev Ilya, Kolpakov Fedor, Kondrakhin Yuriy, Kutumova Elena, Land Sigrid, Laouini Dhafer, Lemaire Julien, Liebich Ines, Manchon Laurent, Matys Volker, Michael Holger, Mkannez Ghada, Noguier Florian, Pierrat Fabien, Rasche Axel, Renard Patricia, Ryabova Anna, Sandoval Ruy Jauregui, Schacherer Frank, Sghaier Rabiaa Manel, Sharipov Ruslan, Stegmaier Philip, Tiffin Nicki, Tolstykh Nikita, Valeev Tagir, Voss Nico, Wierling Christoph, Yevshin Ivan.
The authors declare that they have no competing interests.
IR carried out the hybridization of mouse microarrays and helped to draft the manuscript. SR and RBO performed BMdM preparation and infection experiments, RNA samples preparation and helped to draft the manuscript. MRA carried out the bioinformatics analysis and drafted the manuscript. DP and BT performed qRT-PCR validation. BR participated and supervised the hybridization of mouse microarrays. LGT performed the design and the coordination of the study, analyzed the result and drafted the manuscript. All authors read and approved the final manuscript.
Imen Rabhi, Sameh Rabhi, Rym Ben-Othman, Mohamed Radhouane Aniba contributed equally to this work.